Loading...
XHKG3613
Market cap907mUSD
Dec 23, Last price  
8.42HKD
1D
-0.47%
1Q
9.35%
Jan 2017
-19.66%
IPO
5.91%
Name

Beijing Tong Ren Tang Chinese Medicine Co Ltd

Chart & Performance

D1W1MN
XHKG:3613 chart
P/E
13.04
P/S
4.62
EPS
0.65
Div Yield, %
3.92%
Shrs. gr., 5y
—
Rev. gr., 5y
0.15%
Revenues
1.52b
-11.91%
333,039,000613,963,000761,051,000970,477,0001,084,280,0001,265,994,0001,513,873,0001,432,632,0001,315,346,0001,556,158,0001,731,095,0001,524,945,000
Net income
540m
-16.33%
155,935,000220,001,000287,124,000354,249,000420,315,000489,967,000580,720,000556,118,000542,456,000607,838,000645,875,000540,393,000
CFO
461m
-15.82%
185,096,000142,528,000244,734,000353,576,000467,721,000469,144,000577,684,000551,010,000116,054,000777,170,000547,444,000460,831,000
Dividend
Jun 12, 20240.33 HKD/sh
Earnings
Jun 06, 2025

Profile

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.
URL
https://cm.tongrentang.com/
IPO date
May 07, 2013
Employees
789
Domiciled in
HK
Incorporated in
HK

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,524,945
-11.91%
1,731,095
11.24%
1,556,158
18.31%
Cost of revenue
900,200
930,335
789,488
Unusual Expense (Income)
NOPBT
624,745
800,760
766,670
NOPBT Margin
40.97%
46.26%
49.27%
Operating Taxes
97,203
134,669
126,848
Tax Rate
15.56%
16.82%
16.55%
NOPAT
527,542
666,091
639,822
Net income
540,393
-16.33%
645,875
6.26%
607,838
12.05%
Dividends
(276,243)
(443,663)
(200,904)
Dividend yield
2.71%
4.62%
1.79%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
56,420
42,348
53,202
Long-term debt
206,874
163,264
202,471
Deferred revenue
333
799
Other long-term liabilities
(333)
(799)
Net debt
(2,175,200)
(1,847,968)
(1,467,990)
Cash flow
Cash from operating activities
460,831
547,444
777,170
CAPEX
(21,866)
(38,509)
(23,428)
Cash from investing activities
(1,078,521)
335,412
(265,734)
Cash from financing activities
(372,181)
(535,416)
(278,649)
FCF
338,464
451,332
688,933
Balance
Cash
2,378,693
2,243,963
2,275,568
Long term investments
59,801
(190,383)
(551,905)
Excess cash
2,362,247
1,967,025
1,645,855
Stockholders' equity
4,070,108
3,779,859
3,564,671
Invested Capital
1,790,256
1,734,039
1,989,820
ROIC
29.94%
35.77%
33.63%
ROCE
15.01%
21.59%
21.05%
EV
Common stock shares outstanding
837,100
837,100
837,100
Price
12.16
6.11%
11.46
-14.61%
13.42
64.06%
Market cap
10,179,136
6.11%
9,593,166
-14.61%
11,233,882
64.06%
EV
8,158,113
7,907,447
9,899,266
EBITDA
707,259
876,230
836,642
EV/EBITDA
11.53
9.02
11.83
Interest
5,978
4,661
4,707
Interest/NOPBT
0.96%
0.58%
0.61%